NCT05083468View on ClinicalTrials.gov

The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

October 29, 2021

Primary Completion Date

October 14, 2022

Study Completion Date

October 14, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

SR750 tablet

The volunteers will be orally administrated by single or multiple dose of SR750 tablet with 240 mL water.

DRUG

matching placebo

The volunteers will be orally administrated by single or multiple dose of matching placebo with 240 mL water.

Trial Locations (1)

3004

Nucleus Network Pty Ltd, Melbourne

All Listed Sponsors
lead

Shanghai SIMR Biotechnology Co., Ltd.

INDUSTRY

NCT05083468 - The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers | Biotech Hunter | Biotech Hunter